Viewing Study NCT01522768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-05-31 @ 6:13 PM
Study NCT ID: NCT01522768
Status: COMPLETED
Last Update Posted: 2023-11-01
First Post: 2012-01-25
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophageal Cancer View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ESOPHAGUS View
None STOMACH View
None Afatinib View
None paclitaxel View
None trastuzumab View
None 11-166 View